Roche Holding Ltd. http://www.alacrastore.com/company-snapshot/Roche_Holding_Ltd-1008052 27 Nov 2009 08:17:38 EST 1008052 Roche Holding Ltd. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/research/fitch-ratings-Fitch_European_Pharma_Faces_Declining_Profitability_on_Diversification_Pressures-524736_pr_frame524736_pr_framefitch/524736_pr_framehtmlAstraZeneca plcBayer AGGlaxosmithkline Finance PlcGlaxoSmithKline plcNovartis AGRoche Holding Ltd.Sanofi-Aventis S.A.Smithkline Beecham Corporation803624348045797280457976804579798110870781108717825886838588407329 Oct 2009 10:17:00 EST0103170085Press ReleaseAZNBAYNGSKNOVNROSANFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.ARGCHEDEUESPFRAGBRINDMEXRUSUSA010100000101010001020000010300000103100001031700020200000300000003010000030108000302000003030000040000000401000004020000Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/research/fitch-ratings-Roche_Holding_Ltd-475026_report_frame475026_report_framefitch/475026_report_framepdfRoche Holding Ltd.8258868320 Oct 2009 10:19:00 EST01031700165Credit UpdateROFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.ARGCHEDEUESPGBRMEXUSA01010000010101000102000001030000010310000103170002020000030000000301000003010800030200000303000004000000040100000402000006000000Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/ccbn/T2444704T2444704ccbn/T2444704norm15 Oct 2009 03:05:00 EST2444704Final Transcript of ROG.S sales update conference call or presentation, 15-Oct-09 2:00pm CETRoche Holding AG54.0000FinalQ3 2009 Roche Holding AG Sales Release Conference Call TranscriptROG.S2:00pm CETTranscript...Severin Schwan Roche Group - CEO Bill Burns Roche Pharmaceuticals Division - CEO Juergen Schwiezer Roche Diagnostics Division - CEO Erich Hunziker Roche Group - CFO Karl Mahler Roche Holdings AG - Head of IR Pascal Soriot Genentech, Inc. - CEO... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2444704B2444704ccbn/B2444704norm15 Oct 2009 12:05:00 EST2444704Edited Brief of ROG.S sales update conference call or presentation, 15-Oct-09 2:00pm CETRoche Holding AG54.0000EditedQ3 2009 Roche Holding AG Sales Release Conference Call SummaryROG.S2:00pm CETBrief...Severin Schwan Roche Group - CEO Bill Burns Roche Pharmaceuticals Division - CEO Juergen Schwiezer Roche Diagnostics Division - CEO Erich Hunziker Roche Group - CFO Karl Mahler Roche Holdings AG - Head of IR Pascal Soriot Genentech, Inc. - CEO... Credit & Investment ResearchThomson StreetEventsUS - Gen-Probe Inc definitively agreed to acquire Prodesse Inc, a Waukesha-based biotechnology company, for an estimated USD ## mil in cash.08 Oct 2009 07:50:48 EST36866974517R77119M74517RGen-Probe IncProdesse IncRoche Holding AGProdesse Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Gen_Probe_Inc_acquires_Prodesse_Inc-2115733020sdc/21157330202115733020Copyright © 2009, Thomson Financial, All Rights ReservedDrugsUnited StatesIn vitro and in vivo diagnostic substances2835CACaliforniaSubsidiary2835:In vitro and in vivo diagnostic substances8731:Commercial physical and biological research2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances2869:Industrial organic chemicals, nec2899:Chemicals and chemical preparations, nec3841:Surgical and medical instruments and apparatus6719:Offices of holding companies, nec8731:Commercial physical and biological researchDrugsUnited StatesBiological products, except diagnostic substances2836WIWisconsinPrivate2511002Mnfr pharm,med instrBiotech coCashCash OnlyAssets829312002Oct 8 20090.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000US30 Jun 090.000001.7900095.780000.00000467.046001079.89100U.S. Dollar0.000001.000002.000003.00000Manufacture, research anddevelop diagnostic rDNAproducts used in researchManufacture, research and develop diagnostic rDNA productsused in researchManufacture, research and develop diagnostic rDNA products used in research1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.00000Prodesse Inc, based inWaukesha, Wisconsin, is abiotechnology company thatspecializes in developingmolecular testing forinfluenza and other infectiousdiseases. Its products areused in conjunction withvarious nucleic acidextraction and real-time PCR(polymerase chain reaction)platforms. The company wasfounded in 2003.Prodesse Inc, based in Waukesha, Wisconsin, is abiotechnology company that specializes in developingmolecular testing for influenza and other infectiousdiseases. Its products are used in conjunction with variousnucleic acid extraction and real-time PCR (polymerase chainreaction) platforms. The company was founded in 2003.Prodesse Inc, based in Waukesha, Wisconsin, is a biotechnology company that specializes in developing molecular testing for influenza and other infectious diseases. Its products are used in conjunction with various nucleic acid extraction and real-time PCR (polymerase chain reaction) platforms. The company was founded in 2003.0.000000.000000.000000.00000YU.S. Dollar06 Oct 09Tue, 06 Oct 2009 00:00:00 ESTDate Announced: 10/06/2009Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000060 U.S. Dollar60.000000.0000060 U.S. Dollar60.000000.000000.000000.000000.0000060.0000060 U.S. Dollar1.00000N37.715000.000000.000000.000000.000000.0000060.0000060.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.00000US - Gen-Probe Incdefinitively agreed toacquire Prodesse Inc, aWaukesha-based biotechnologycompany, for an estimated USD60 mil in cash.US - Gen-Probe Inc definitively agreed to acquire Prodesse Inc, a Waukesha-based biotechnology company, for an estimated USD 60 mil in cash.US - Gen-Probe Inc definitively agreed to acquire Prodesse Inc, a Waukesha-basedbiotechnology company, for an estimated USD 60 mil in cash.US - Gen-Probe Inc definitively agreed to acquire Prodesse Inc, a Waukesha-based biotechnology company, for an estimated USD 60 mil in cash.US - Gen-Probe Inc definitively agreed to acquire Prodesse Inc, a Waukesha-based biotechnology company, for an estimated USD 60 mil incash.Pending770.7780095.78000467.046001079.891000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations121305001ZurichSwitzerland2834ForeignPublicROG2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations829312002United States2836WisconsinPrivate60.0000060.0000060.0000037.71500Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/ccbn/B2440786B2440786ccbn/B2440786norm25 Sep 2009 04:05:00 EST2440786Edited Brief of ROG.S conference call or presentation, 25-Sep-09 2:30pm CETRoche Holding AG54.0000EditedRoche Holding AG Investor Science Event: Conference Call from ECCO ESMO 2009 SummaryROG.S2:30pm CETBrief...Karl Mahler Roche Holding AG - Head of IR Sandra Horning R o c h e H o l d i n g A G - SVPandGlobalHeadofClinicalDevelopmentOncology/HematologyandHeadoftheDiseaseBiologyLeadershipTeam Varun Nanda Roche Holding AG - Global Product Strategy, Head Oncology Philippe Bishop Roche Holding AG - VP, Clinical Development, Avastin Niko Andre Roche Holding AG - Global Medical Director, Avastin Franchise Stefan Frings Roche Holding AG - Global HER# Franchise Leader CONFERENCE CALL PARTICIPANTS... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2440786T2440786ccbn/T2440786norm25 Sep 2009 03:05:00 EST2440786Final Transcript of ROG.S conference call or presentation, 25-Sep-09 2:30pm CETRoche Holding AG54.0000FinalRoche Holding AG Investor Science Event: Conference Call from ECCO ESMO 2009 TranscriptROG.S2:30pm CETTranscript...Karl Mahler Roche Holding AG - Head of IR Sandra Horning Roche Holding AG - SVP and Global Head of Clinical Development Oncology/Hematology and Head of the Disease Biology Leadership Team Varun Nanda Roche Holding AG - Global Product Strategy, Head Oncology Philippe Bishop Roche Holding AG - VP, Clinical Development, Avastin Niko Andre Roche Holding AG - Global Medical Director, Avastin Franchise Stefan Frings Roche Holding AG - Global HER# Franchise Leader C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/research/s-and-p-credit-research-Summary_Roche_Holding_AG-746645746645spcred/746645normglobal15 Sep 2009 12:58:00 EST175SummaryThe latest Summary from S&PSwitzerlandPharmaceuticalsEurope, Middle East, AfricaSummaryCHE35202010 352020 3520 35Roche Holding AG395852EUROMIDAFRROG@VXSUMMARYConsumerCORPGLOBISSHealthGlobal IssuersCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/fitch/465450_report_frame465450_report_framefitch/465450_report_framepdfEli Lilly & CompanySanofi-Aventis S.A.Glaxosmithkline Finance PlcWyethPfizer Inc.Merck & Company, Inc.Roche Holding Ltd.Bristol-Myers Squibb CompanyAbbott LaboratoriesJohnson & JohnsonAstraZeneca plcBayer AGNovartis AGSchering-Plough CorporationAmgen, Inc.85884073803616308045797680656236803615928084388480361372803624348071041080361419811087078009174082588683850944738045797910 Sep 2009 02:17:00 EST01031700275Special ReportJNJWYESANBMYAMGNABTROBAYNMRKPFELLYSGPAZNNOVNFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch ResearchBRAZIL - In August ####, F Hoffmann-La Roche Ltd, a Switzerland based drug manufacturers announced that it was seeking a buyer for its Jacarepagua factory, Brazil, manufacture pharmaceuticals and biological products.26 Aug 2009 11:56:20 EST81572I43501L81572I77119MSeeking BuyerF Hoffmann-La Roche Ltd- Jacarepagua FactorySeeking BuyerRoche Holding AGhttp://www.alacrastore.com/storecontent/Thomson_M%26A/Roche_Holding_AG_seeking_buyer_for_F_Hoffmann_La_Roche_Ltd-2101786040sdc/21017860402101786040Copyright © 2009, Thomson Financial, All Rights ReservedInvestment & Commodity Firms,Dealers,ExchangesUnknownInvestors, nec6799UNUnknownPrivate6799:Investors, nec6799:Investors, necDrugsBrazilPharmaceutical preparations2834FFForeignSubsidiary12029001Seeking buyerMnfr pharm,med instrNot ApplicableAssets1100678001Aug 26 20090.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.00000Seeking buyerSeeking buyerSeeking buyer1.000002.000003.000004.000005.000006.00000F Hoffmann-La RocheLtd-Jacarepagua Factory,located in Jacarepagua,Brazil, manufacturepharmaceuticals and biologicalproducts.F Hoffmann-La Roche Ltd-Jacarepagua Factory, located inJacarepagua, Brazil, manufacture pharmaceuticals andbiological products.F Hoffmann-La Roche Ltd-Jacarepagua Factory, located in Jacarepagua, Brazil, manufacture pharmaceuticals and biological products.0.000000.000000.000000.00000N22 Aug 09Sat, 22 Aug 2009 00:00:00 ESTDate Announced: 08/22/2009Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.000000.000000.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000BRAZIL - In August 2009, FHoffmann-La Roche Ltd, aSwitzerland based drugmanufacturers announced thatit was seeking a buyer forits Jacarepagua factory,Brazil, manufacturepharmaceuticals andbiological products.BRAZIL - In August 2009, F Hoffmann-La Roche Ltd, a Switzerland based drug manufacturers announced that it was seeking a buyer for its Jacarepagua factory, Brazil, manufacture pharmaceuticals and biological products.BRAZIL - In August 2009, F Hoffmann-La Roche Ltd, a Switzerland based drug manufacturersannounced that it was seeking a buyer for its Jacarepagua factory, Brazil, manufacturepharmaceuticals and biological products.BRAZIL - In August 2009, F Hoffmann-La Roche Ltd, a Switzerland based drug manufacturers announced that it was seeking a buyer for its Jacarepagua factory, Brazil, manufacture pharmaceuticals andbiological products.BRAZIL - In August 2009, F Hoffmann-La Roche Ltd, a Switzerland based drug manufacturers announced that it was seeking a buyer for itsJacarepagua factory, Brazil, manufacture pharmaceuticals and biological products.S Buyer0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:S Buyer-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances2869:Industrial organic chemicals, nec2899:Chemicals and chemical preparations, nec3841:Surgical and medical instruments and apparatus12029001Unknown6799UnknownPrivate2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances2869:Industrial organic chemicals, nec2899:Chemicals and chemical preparations, nec3841:Surgical and medical instruments and apparatus6719:Offices of holding companies, nec8731:Commercial physical and biological research121305001ZurichSwitzerland2834ForeignPublicROG0.000000.000000.000000.00000Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/moodys/PR_182582_600035606PR_182582_600035606moodys/PR_182582_600035606html07 Jul 2009 05:01:01 ESThtmlRoche Holding AGGenentech, Inc.Roche Holdings Inc.Genentech, Inc.; Roche Holding AG; Roche Holdings Inc.60003560631335016530150.000006 Jul 2009NewsRating ActionCGlobal Credit Research Rating Action # JUL #### Rating Action: Roche Holding AG Moody's withdraws ratings of Genentech Approximately $# billion of long term debt affected New York, July ##, #### -- Moody's Investors Service withdrew...Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/fitch/445486_report_frame445486_report_framefitch/445486_report_framepdfNovartis AGBayer AGAstraZeneca plcSanofi-Aventis S.A.WyethSchering-Plough CorporationBristol-Myers Squibb CompanyEli Lilly & CompanyPfizer Inc.Amgen, Inc.Merck & Company, Inc.Johnson & JohnsonAbbott LaboratoriesGlaxoSmithKline plcRoche Holding Ltd.85094473804579798036141985884073803613728065623680710410800917408036243480361630804579728084388482588683804579768036159208 Jun 2009 02:14:00 EST01031700275Special ReportSANABTMRKNOVNLLYGSKROAMGNJNJBAYPFEBMYAZNSGPWYEFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/fitch/467701_pr_frame467701_pr_framefitch/467701_pr_framehtmlRoche Holding Ltd.GlaxoSmithKline plcBayer AGSmithkline Beecham CorporationNovartis AGSanofi-Aventis S.A.Glaxosmithkline Finance PlcAstraZeneca plc858840738045797680457979804579728110871780362434811087078258868309 Apr 2009 02:14:00 EST010317000103170385Press ReleaseBAYSANROGSKNOVNAZNFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/fitch/432148_report_frame432148_report_framefitch/432148_report_framepdfAmgen, Inc.Eli Lilly & CompanyGlaxoSmithKline plcJohnson & JohnsonNovartis AGRoche Holding Ltd.Abbott LaboratoriesSchering-Plough CorporationBristol-Myers Squibb CompanyWyethSanofi-Aventis S.A.AstraZeneca plcBayer AGMerck & Company, Inc.Pfizer Inc.80361372803614198036163080710410803615928258868380656236804579728509447380457979800917408045797680843884858840738036243409 Apr 2009 10:14:00 EST01031700275Special ReportSANBAYBMYSGPNOVNLLYABTMRKPFEAZNAMGNWYEJNJROGSKFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/fitch/429818_report_framefitch/429818_report_framepdf429818_report_frameFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Roche Holding Ltd.8258868323 Mar 2009 10:12:00 EST01031700425Full Rating ReportROCredit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/spcred/709428spcred/709428norm709428The latest Summary from S&Pglobal18 Mar 2009 03:45:00 EST175SummarySwitzerlandPharmaceuticalsEurope, Middle East, AfricaHealth CareCorporationsConsumer ProductsGlobal IssuersSummaryCHE35202010 352020 3520 35Roche Holding AG395852EUROMIDAFRROG@VXSUMMARYGLOBISSConsumerHealthCORPCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/709242spcred/709242norm709242The latest Full Report from S&Pstructured17 Mar 2009 03:24:04 EST400Full ReportSwitzerlandPharmaceuticalsEurope, Middle East, AfricaGlobal IssuersHealth CareAsset-Backed SecuritiesConsumer ProductsCorporationsStructured FinanceFinancial InstitutionsFull ReportCHE35202010 352020 3520 35Roche Holding AG395852EUROMIDAFRROG@VXFULLUSA36871035201010 352010 3520 35Genentech Inc.347136EUROMIDAFRUSADNAConsumerHealthFICORPABSGLOBISSSTRUCCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/fitch/464657_pr_framefitch/464657_pr_framehtml464657_pr_frameFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Roche Holding Ltd.8258868313 Mar 2009 10:15:00 EST0103170085Press ReleaseROCredit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/moodys/CMT_0000478908moodys/CMT_0000478908htmlCMT_0000478908Global Credit Research Issuer Comment # MAR #### Issuer Comment: Roche Holding AG Moody's comments on Roche's increased offer price for Genentech; review continues Moody's Investors Service has today said that Roche Holding AG's (Roche)...10 Mar 2009 04:56:01 ESThtmlRoche Holding AGRoche Holding AG600035606150.0000NewsIssuer CommentCredit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/fitch/426906_report_framefitch/426906_report_framepdf426906_report_frameFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Roche Holding Ltd.8258868320 Feb 2009 10:17:35 EST01031700165Credit UpdateROCredit & Investment ResearchFitch Research